Tasly Holding Group Overview
- Founded
- 1994

- Status
- Public
- Employees
- 5,807

- Stock Symbol
- 600535

- Investments
- 33
- Share Price
- $1.54
- (As of Tuesday Closing)
Tasly Holding Group General Information
Description
Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.
Contact Information
- Securities Department, Tasly Pharmaceutical Co. ltd
- Tasly TCM Garden, Pu Jihe East Road No.2, Beichen District
- Tianijn, 300410
- China
Tasly Holding Group Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.54 | $1.59 | $1.47 - $2.71 | $2.4B | 1.51B | 19.9M | $0.15 |
Tasly Holding Group Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 3,354,291 | 3,702,345 | 3,638,458 | 4,293,937 |
Revenue | 1,254,129 | 1,231,510 | 1,965,101 | 2,749,537 |
EBITDA | 283,512 | 504,009 | 327,677 | 309,002 |
Net Income | 230,167 | 365,315 | 162,969 | 144,932 |
Total Assets | 2,576,354 | 2,595,121 | 2,552,545 | 3,432,131 |
Total Debt | 279,382 | 265,697 | 455,702 | 1,156,147 |
Tasly Holding Group Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Tasly Holding Group‘s full profile, request access.
Request a free trialTasly Holding Group Patents
Tasly Holding Group Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2021519335-A | Pharmaceutical compositions and their uses | Pending | 04-Apr-2018 | 0000000000 | |
CA-3090831-A1 | Pharmaceutical composition and application thereof | Pending | 04-Apr-2018 | 0000000000 | |
AU-2019248307-A1 | Pharmaceutical composition and application thereof | Pending | 04-Apr-2018 | 0000000000 | |
CA-3093031-A1 | Traditional chinese medicinal composition for preventing and/or treating ischemic reperfusion injury | Pending | 04-Apr-2018 | 0000000000 | |
EP-3777871-A1 | Traditional chinese medicine composition for preventing and/or treating ischemic reperfusion injury | Pending | 04-Apr-2018 | A61K36/537 |
Tasly Holding Group Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Yan XiJun | Founder & President | ||
Jie Wei | Finance Director |
Tasly Holding Group Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
0000000 000 | Tasly Holding Group | Director | 000 0000 |
00000 0000 | Tasly Holding Group | Board Member | 000 0000 |
Tasly Holding Group Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTasly Holding Group Investments & Acquisitions (33)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000000000 | 26-Jan-2022 | 00000 0000 | Educational and Training Services (B2C) | ||
0000000 00000 | 21-May-2021 | 00000 0000 | 000.00 | Drug Discovery | |
0000 0000000 | 10-Nov-2020 | 00000 0000 | 000.00 | Enterprise Systems (Healthcare) | |
000000000 000 | 14-May-2020 | 000000000 | 000.00 | Medical Supplies | |
Avicanna | 21-Apr-2020 | PIPE | 00.000 | Pharmaceuticals |
Tasly Holding Group Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
Tasly Capital | Corporate Venture Capital | Beijing, China | 2008 |
0000000 0000000000 | Pharmaceuticals | Tianjin, China | 0000 |
Tasly Holding Group Exits (6)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000000000 0000000 | 14-May-2020 | 000000000 00000000 | 000.00 | Completed |
|
0-000 000000000 | 06-Jul-2018 | 00000 00000 00 | 00000 | Completed |
|
0-000 000000000 | 23-Mar-2017 | 00000 00000 00 | 00000 | Completed |
|
00000000 | 03-Jan-2017 | 00000 00000 00 | 00000 | Completed |
|
I-Mab Biopharma | 01-Oct-2016 | Early Stage VC | 0000 | Completed |
|